Download PDFPDF

Attitude towards active surveillance: a cross-sectional survey among patients with uroandrological disorders
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Moncada's Manoeuvre is useful and reliable also in urological disorders.
    • Sergio Stagnaro, Director Quantum Biophysical Semeiotic Research Laboratory
    • Other Contributors:
      • Simone Caramel, President
      • Marco Marchionni, Brain Surgeon

    The Moncada's Manoeuvre, among a lot of other clinical manoeuvres and signs, allows doctors to bedside differentiate easily and quickly benigne from, even initally, malignant disorders (1-3).
    For instance, the differential diagnosis between urinary tract hemorrhage benign or malignant in nature is often difficult ayt the bedside. In addition, Moncada 'Manoeuvre proved to be very useful in the differential diagnosis between prostate adenoma and prostate cancer, even initial, as Oncological Terrain-Dependent, Inherited Real Risk..
    1)Sergio Stagnaro (2018).Manovra di Moncada*: Diagnosi Differenziale tra Lesione Benigna e Maligna in 15 secondi. in pdf
    2) Sergio Stagnaro. Massucco’s Sign in the war against to Prostate Cancer. Letter to FDA; ; 2 May, 2010,
    3) Sergio Stagnaro. Bedside Detecting Inherited Real Risk of Prostate Cancer, and overt Cancer: Massucco’s Sign. European Urology. 27 April, 2011,

    Conflict of Interest:
    None declared.